Vickas Agarwal, MD
Oral & Maxillofacial Surgery · Richmond, VANPI 1164961454
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,461 of the $3,421 with a category attached, or 71.9%. 9 manufacturers reported payments, led by Biocircuit Technologies Inc at 34.2% of the total. 2025 is the largest year on record at $1,829, 2.2 times the $839 reported in 2023.
Across 35 payments — averaging $97.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biocircuit Technologies Inc$1K
- Stryker$945
- Axogen$803
- Zimvie Inc.$190
- Johnson & Johnson$185
- Geistlich Pharma, North America, Inc.$69
- plus $58 from 3 others
What the payments were for
- Consulting fees$96028%
- Food & beverage$2,46172%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biocircuit Technologies Inc | 3 | $1,171 |
| Stryker | 10 | $945 |
| Axogen | 9 | $803 |
| Zimvie Inc. | 4 | $190 |
| Johnson & Johnson | 5 | $185 |
| Geistlich Pharma, North America, Inc. | 1 | $69 |
| Integra Lifesciences Corporation | 1 | $25 |
| Kls-martin L.p. | 1 | $17 |
| Nobel Biocare USA | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,421 in reported general payments places this provider in the 80th percentile of 231 oral & maxillofacial surgery providers in Virginia.
See all oral & maxillofacial surgery providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine Hcl ViscousLidocaine Hcl | 13 | $373 |
| Chlorhexidine Gluconate | 31 | $139 |
Paid to pharmacies, not to this prescriber.
Other oral & maxillofacial surgery in Richmond
- James NelsonRichmond$163K
- Abubaker AbubakerRichmond$8K
- Charles BoxxRichmond$3K
- Samuel TackRichmond$3K
- Yotom RabinowitzRichmond$3K
- Joseph NiamtuMidlothian$71K
- Mohamed HakimArlington$52K
- David BitontiNorfolk$44K
- Leonel PerezAnnandale$41K
- Ali PashapourArlington$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.